TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Örn Almarsson, PhD
Head of Formulations at Moderna Therapeutics

Profile

Dr. Örn Almarsson is head of formulation at Moderna Therapeutics, a company in Cambridge MA pioneering messenger RNA therapeutics. In his 24-year career in pharma/biotech, Örn has worked broadly on the materials science of drug delivery, including Preformulation activities, crystalline materials, pharmaceutical cocrystals, nanotechnologies, prodrugs, biopharmaceutical evaluation and stabilization of formulations. He received his B.Sc. in chemistry from the University of Iceland and Ph.D. in bio-organic chemistry from UC Santa Barbara working with prof. Thomas C. Bruice. Örn started his industry career at Merck Research Laboratories in Pharmaceutical R&D following post-doctoral work at MIT with prof. Alexander Klibanov.

Örn Almarsson, PhD's Network

Agenda Sessions

  • mRNA Vaccines and Therapeutics: From Promise to Reality

    , 10:25